Skip to main navigation Skip to search Skip to main content

Adenoviral targeting of malignant melanoma for fluorescenceguided surgery prevents recurrence in orthotopic nude-mouse models

  • Shuya Yano
  • , Kiyoto Takehara
  • , Hiroyuki Kishimoto
  • , Yasuo Urata
  • , Shunsuke Kagawa
  • , Michael Bouvet
  • , Toshiyoshi Fujiwara
  • , Robert M. Hoffman

Research output: Contribution to journalArticlepeer-review

Abstract

Malignant melanoma requires precise resection in order to avoid metastatic recurrence. We report here that the telomerase-dependent, green fluorescent protein (GFP)-containing adenovirus OBP-401 could label malignant melanoma with GFP in situ in orthotopic mouse models. OBP-401-based fluorescence-guided surgery (FGS) resulted in the complete resection of malignant melanoma in the orthotopic models, where conventional bright-light surgery (BLS) could not. High-dose administration of OBP-401 enabled FGS without residual cancer cells or recurrence, due to its dual effect of cancer-cell labeling with GFP and killing.

Original languageEnglish
Pages (from-to)18558-18572
Number of pages15
JournalOncotarget
Volume7
Issue number14
DOIs
Publication statusPublished - 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Adenovirus
  • Fluorescence-guided surgery (FGS)
  • Melanoma
  • Nude mice
  • OBP-401

ASJC Scopus subject areas

  • Oncology

Fingerprint

Dive into the research topics of 'Adenoviral targeting of malignant melanoma for fluorescenceguided surgery prevents recurrence in orthotopic nude-mouse models'. Together they form a unique fingerprint.

Cite this